Skip to main content

PEAK6 LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1389958 AUSTIN, TX

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$2,283,150
+$2,280,835 QoQ
Shares Held
2,955
+98400.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Mar 31, 2026
CallValue
$4,713,104
CallShares
6,100
PutValue
$463,584
PutShares
600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

PEAK6 LLC holds $24,388,144 across 19 Biotechnology names. REGN ranks #6 (9.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 REGN
Regeneron Pharmaceuticals, Inc.
This page
2,955 $2,283,150

All Filings in REGN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,713,104 6,100
2026-03-31 $463,584 600
2026-03-31 $2,283,150 2,955
2025-12-31 $2,315 3
2025-12-31 $77,187 100
2025-12-31 $30,411,678 39,400
2025-09-30 $14,900,155 26,500
2025-09-30 $23,671,567 42,100
2025-09-30 $6,661,211 11,847
2025-06-30 $42,525,000 81,000
2025-06-30 $19,545,750 37,230
2025-06-30 $30,502,500 58,100
2025-03-31 $6,469,146 10,200
2024-12-31 $7,408,232 10,400
2024-12-31 $2,493,155 3,500
2024-12-31 $712 1